Full Breakdown
Johnson & Johnson Faces Record $1.5 Billion Verdict Over Talc Products
12/23/2025, 12:09:57 PM
Baltimore Jury Awards Damages for Asbestos-Linked Cancer
A Baltimore jury has ordered Johnson & Johnson (J&J) and its subsidiaries to pay over $1.5 billion to Cherie Craft, a woman who claimed that decades of exposure to asbestos in the company's talc-based products led to her diagnosis of peritoneal mesothelioma, a rare form of cancer. The jury found J&J and its subsidiary Kenvue liable for failing to adequately warn Craft about the asbestos content in its baby powder. The award includes $59.84 million in compensatory damages and $1.5 billion in punitive damages, marking the largest single-plaintiff verdict against J&J to date. Craft, who was diagnosed in January 2024, has been active in nonprofit work, emphasizing the preventability of her condition.
Ongoing Legal Challenges and Company Response
Johnson & Johnson has announced plans to appeal the verdict, labeling it as “egregious” and “patently unconstitutional.” Erik Haas, J&J’s vice president of litigation, criticized the ruling as resulting from “gross errors” by the trial court and argued that it contradicts the outcomes of most talc-related cases where the company has prevailed. J&J maintains that its talc products are safe and free from asbestos, citing decades of studies to support its claims. The company has faced over 67,000 lawsuits alleging that its talc products caused various cancers, including ovarian cancer and mesothelioma, which it consistently denies.
Recent Verdicts and Broader Implications
The Baltimore verdict follows a series of significant legal setbacks for J&J, including a $40 million award to two women in California who claimed their ovarian cancer was linked to the company's talc products. Earlier in October 2025, a California jury awarded $966 million in a mesothelioma case related to talc exposure. These verdicts contribute to a growing legal landscape where J&J has set aside billions for litigation costs and settlements while continuing to fight claims in courts across the United States.
Criticism and Opposition
Critics argue that J&J has long been aware of the potential risks associated with asbestos contamination in its talc products but failed to inform consumers adequately. Jessica Dean, a partner at Dean Omar Branham Shirley, representing Craft, stated, “J&J refused to accept any responsibility and fought at every turn.” This sentiment reflects a broader concern regarding corporate accountability and consumer safety in the context of long-term product exposure.
What's Next for Johnson & Johnson
As J&J prepares to appeal the Baltimore verdict, the company also faces upcoming federal bellwether trials that will address talcum powder cancer lawsuits. These trials, consolidated in the District of New Jersey, are expected to influence future settlements and the overall legal strategy of J&J. The ongoing litigation and public scrutiny surrounding talc products underscore the intersection of science, law, and consumer trust, as the debate over the safety of talc continues to evolve.
Verbatim Quotes
- “Cherie Craft runs a non-profit where she pours her life into helping others. Her cancer was preventable. She used Johnson’s Baby Powder every day of her life until she was diagnosed with cancer,” — Jessica Dean, Partner at Dean Omar Branham Shirley
- “We will immediately appeal this verdict,” — Erik Haas, J&J’s Worldwide Vice President of Litigation
- “These lawsuits are predicated on junk science,” — Erik Haas, J&J’s Worldwide Vice President of Litigation
The outcomes of these cases will likely have lasting implications for both Johnson & Johnson and the broader public health discourse surrounding talc products.
